Literature DB >> 23870096

Carbapenemase-producing Enterobacteriaceae in Europe: a survey among national experts from 39 countries, February 2013.

C Glasner1, B Albiger, G Buist, A Tambić Andrasević, R Canton, Y Carmeli, A W Friedrich, C G Giske, Y Glupczynski, M Gniadkowski, D M Livermore, P Nordmann, L Poirel, G M Rossolini, H Seifert, A Vatopoulos, T Walsh, N Woodford, T Donker, D L Monnet, H Grundmann.   

Abstract

The spread of carbapenemase-producing Enterobacteriaceae (CPE) is a threat to healthcare delivery, although its extent differs substantially from country to country. In February 2013, national experts from 39 European countries were invited to self-assess the current epidemiological situation of CPE in their country. Information about national management of CPE was also reported. The results highlight the urgent need for a coordinated European effort on early diagnosis, active surveillance, and guidance on infection control measures.

Mesh:

Substances:

Year:  2013        PMID: 23870096     DOI: 10.2807/1560-7917.es2013.18.28.20525

Source DB:  PubMed          Journal:  Euro Surveill        ISSN: 1025-496X


  83 in total

1.  Evaluation of Two Phenotypic Screening Tests for Carbapenemase-Producing Enterobacteriaceae.

Authors:  Alix Pantel; Dimitri Souzy; Albert Sotto; Jean-Philippe Lavigne
Journal:  J Clin Microbiol       Date:  2015-07-29       Impact factor: 5.948

2.  Antibiotic resistance: the last resort.

Authors:  Maryn McKenna
Journal:  Nature       Date:  2013-07-25       Impact factor: 49.962

3.  Increasing incidence of carbapenemase-producing Escherichia coli and Klebsiella pneumoniae in Belgian hospitals.

Authors:  M De Laveleye; T D Huang; P Bogaerts; C Berhin; C Bauraing; P Sacré; A Noel; Y Glupczynski
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-09-17       Impact factor: 3.267

4.  Bacteriology and antimicrobial susceptibility of ESBLs producers from pus in patients with abdominal trauma associated intra-abdominal infections.

Authors:  S Fan; J Wang; Y Li; J Li
Journal:  Eur J Trauma Emerg Surg       Date:  2016-02-23       Impact factor: 3.693

5.  Co-colonization by multidrug-resistant bacteria in two Greek intensive care units.

Authors:  M Papadimitriou-Olivgeris; I Spiliopoulou; M Christofidou; D Logothetis; P Manolopoulou; V Dodou; F Fligou; M Marangos; E D Anastassiou
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-07-15       Impact factor: 3.267

6.  Carbapenem-Resistant Enterobacteriaceae: Laboratory Detection and Infection Control Practices.

Authors:  Eva-Brigitta Kruse; Ute Aurbach; Hilmar Wisplinghoff
Journal:  Curr Infect Dis Rep       Date:  2013-10-12       Impact factor: 3.725

7.  Spread of NDM-1-producing Enterobacteriaceae in a neonatal intensive care unit in Istanbul, Turkey.

Authors:  Laurent Poirel; Mesut Yilmaz; Ayse Istanbullu; Ferhat Arslan; Ali Mert; Sandrine Bernabeu; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2014-02-18       Impact factor: 5.191

8.  The global challenge of carbapenem-resistant Enterobacteriaceae in transplant recipients and patients with hematologic malignancies.

Authors:  Michael J Satlin; Stephen G Jenkins; Thomas J Walsh
Journal:  Clin Infect Dis       Date:  2014-01-23       Impact factor: 9.079

9.  OXA-48 carbapenemase-producing Salmonella enterica serovar Kentucky isolate of sequence type 198 in a patient transferred from Libya to Switzerland.

Authors:  Salome N Seiffert; Vincent Perreten; Sönke Johannes; Sara Droz; Thomas Bodmer; Andrea Endimiani
Journal:  Antimicrob Agents Chemother       Date:  2014-01-27       Impact factor: 5.191

10.  In Vitro Antimicrobial Activity of a Siderophore Cephalosporin, S-649266, against Enterobacteriaceae Clinical Isolates, Including Carbapenem-Resistant Strains.

Authors:  Naoki Kohira; Joshua West; Akinobu Ito; Tsukasa Ito-Horiyama; Rio Nakamura; Takafumi Sato; Stephen Rittenhouse; Masakatsu Tsuji; Yoshinori Yamano
Journal:  Antimicrob Agents Chemother       Date:  2015-11-16       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.